Compass therapeutics reports second quarter 2023 financial results and provides corporate update

Boston, aug. 03, 2023 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today reported second quarter, and year-to-date, 2023 financial results.
CMPX Ratings Summary
CMPX Quant Ranking